TownSquare Capital’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,933
Closed -$493K 510
2025
Q2
$493K Sell
5,933
-41,451
-87% -$3.46M 0.05% 345
2025
Q1
$3.98M Sell
47,384
-7,622
-14% -$709K 0.04% 380
2024
Q4
$5.07M Buy
55,006
+7,053
+15% +$678K 0.06% 308
2024
Q3
$4.45M Buy
47,953
+13,210
+38% +$1.14M 0.05% 327
2024
Q2
$2.86M Buy
34,743
+3,950
+13% +$290K 0.04% 404
2024
Q1
$2.04M Buy
30,793
+8,621
+39% +$532K 0.03% 465
2023
Q4
$1.26M Buy
22,172
+8,175
+58% +$428K 0.02% 537
2023
Q3
$763K Buy
13,997
+3,975
+40% +$236K 0.01% 634
2023
Q2
$674K Buy
+10,022
New +$611K 0.01% 659

Other funds holding LMAT

TownSquare Capital's LMAT Position: Q3 2025 in Review

TownSquare Capital sold out of LeMaitre Vascular (LMAT) in Q3 2025, closing a stake of 5,933 shares — an estimated $493K sold.

TownSquare Capital first reported a position in LMAT in Q2 2023 and held it in 9 quarters. The position peaked at $5.07M in Q4 2024. 297 funds tracked by Wall St. Rank hold LMAT as of Q3 2025.

  • TownSquare Capital reported no remaining LeMaitre Vascular position as of Q3 2025 after selling out during the quarter.
  • TownSquare Capital sold 5,933 LeMaitre Vascular shares in Q3 2025, an estimated $493K.
  • TownSquare Capital first reported a position in LeMaitre Vascular in Q2 2023 and held it in 9 quarters.
  • TownSquare Capital's LeMaitre Vascular position peaked at $5.07M in Q4 2024.
  • 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2025.

Based on TownSquare Capital's 13F filing for Q3 2025, filed 3 Nov 2025.